+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Contract Type, Production Scale, Application - Global Forecast 2026-2032- Product Image
Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Contract Type, Production Scale, Application - Global Forecast 2026-2032- Product Image
Sale

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Contract Type, Production Scale, Application - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968717
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Contract Manufacturing Market is projected to reach USD 164.71 Billion in 2026. It is expected to continue growing at a CAGR of 10.06%, reaching USD 297.88 Billion by 2032.

Pharmaceutical contract manufacturing has become a strategic operating model for biopharmaceutical companies seeking scalable capacity, specialized technical capabilities, and resilient supply. Contract development and manufacturing organizations (CDMOs) now support the full value chain, including active pharmaceutical ingredient (API) synthesis, biologics manufacturing, sterile fill-finish, oral solid dose production, analytical testing, packaging, serialization, and commercial supply.

Demand is supported by verified industry signals: the U.S. FDA Center for Drug Evaluation and Research approved 55 novel drugs in 2023 and 50 in 2024, while biologics, high-potency compounds, cell and gene therapies, and complex injectables continue to require dedicated infrastructure and advanced quality systems. As sponsors balance cost, speed, compliance, and geographic risk, pharmaceutical outsourcing is increasingly viewed as a core component of market access and lifecycle management rather than a tactical capacity decision.

Transformative Shifts in the Pharmaceutical Outsourcing Landscape

The landscape is shifting from capacity-based outsourcing to capability-led partnerships. Sponsors are prioritizing CDMOs with demonstrated compliance records, integrated development-to-commercial services, containment expertise for high-potency APIs, and flexible manufacturing networks that can support accelerated clinical timelines and commercial scale-up.

Regulatory expectations are also reshaping competition. The EU GMP Annex 1 revision strengthened requirements for sterile manufacturing and contamination control, while ICH Q9(R1) reinforced formal quality risk management. These frameworks are raising the value of digital quality systems, validated automation, real-time environmental monitoring, and robust supplier qualification across pharmaceutical contract manufacturing operations.

Cumulative Impact of Artificial Intelligence on CDMO Operations

Artificial intelligence is creating cumulative value across CDMO operations by improving demand planning, deviation detection, process optimization, batch record review, and predictive maintenance. FDA reporting indicates more than 300 drug and biologic submissions referenced AI or machine learning between 2016 and 2023, confirming that AI is moving from experimentation into regulated development and manufacturing workflows.

In contract manufacturing, the strongest near-term impact is expected in quality and operational efficiency rather than full process autonomy. AI-enabled analytics can reduce investigation cycle times, identify recurring root causes, and strengthen continued process verification, but adoption must remain aligned with data integrity, validation, cybersecurity, and human oversight requirements under GMP.

Key Regional Insights Across Global Pharmaceutical Manufacturing

Asia-Pacific remains a pivotal region for pharmaceutical contract manufacturing because China, India, Japan, South Korea, and Australia combine API capacity, biologics investment, skilled scientific labor, and expanding regulatory maturity. India is widely recognized as a major global supplier of generic medicines and vaccines, while China continues to strengthen biologics and API capabilities under tighter environmental and quality controls.

North America is anchored by the United States and Canada, where innovation pipelines, FDA-regulated manufacturing, and demand for sterile injectables, biologics, and advanced therapies sustain premium CDMO services. Latin America, led by Brazil and Mexico, is gaining attention for regional supply resilience and access to large public health systems, although regulatory harmonization and technology transfer readiness remain important differentiators.

Europe benefits from mature GMP infrastructure, strong pharmaceutical clusters in Germany, France, Italy, Spain, and the United Kingdom, and demand for specialized manufacturing under EMA and national authority oversight. The Middle East is investing in localization, with GCC countries prioritizing pharmaceutical security and technology transfer, while Africa’s opportunities are linked to essential medicines, vaccine capacity, and long-term public-private manufacturing initiatives focused on improved regional access.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is becoming more relevant for secondary manufacturing, packaging, and regional distribution as member economies invest in healthcare access and regulatory alignment. The GCC is pursuing pharmaceutical localization to reduce import dependence, creating opportunities for technology transfer, fill-finish, and branded generic production.

The European Union remains one of the most highly regulated and strategically important pharmaceutical manufacturing blocs, supported by harmonized GMP standards and cross-border supply chains. BRICS countries collectively influence global API supply, generics manufacturing, and healthcare demand, with China and India holding particularly significant positions in pharmaceutical inputs and finished-dose production.

G7 markets remain central to high-value outsourcing because they concentrate innovative drug development, advanced regulatory expectations, and sophisticated quality requirements. NATO economies are also reassessing medical supply chain resilience, making domestic and allied-nation manufacturing capacity more strategically important for essential medicines, injectables, vaccines, and critical healthcare products.

Key Country Insights Across Leading Pharmaceutical Manufacturing Markets

The United States remains the largest innovation-driven outsourcing environment, supported by FDA oversight, venture-backed biotechnology, and sustained demand for clinical and commercial manufacturing. Canada offers strong biologics and clinical manufacturing capabilities, while Mexico benefits from proximity to the U.S. market, competitive production economics, and growing interest in nearshore pharmaceutical packaging and finished-dose services.

Brazil is Latin America’s largest pharmaceutical market and supports opportunities in generics, biosimilars, and public health supply. The United Kingdom maintains strength in life sciences research and advanced therapy development, while Germany, France, Italy, and Spain provide established GMP manufacturing ecosystems, skilled labor, and strong links to European supply chains. Russia retains domestic production priorities, particularly for essential medicines and import substitution.

China continues to scale API, biologics, and integrated CDMO services, while India remains a global leader in generics, APIs, and vaccine manufacturing. Japan emphasizes high-quality manufacturing and regulatory precision, Australia supports clinical trial supply and specialized biomanufacturing, and South Korea has become a recognized center for large-scale biologics and biosimilar production.

Actionable Recommendations for Pharmaceutical Industry Leaders

Industry leaders should prioritize dual-source strategies, validated technology transfer playbooks, and transparent supplier risk scoring across API, excipient, component, and finished-dose networks. CDMO selection should weigh regulatory history, audit performance, capacity flexibility, data integrity maturity, and experience with the target modality rather than cost alone.

Executives should also invest in digital quality management, AI-ready data architecture, and advanced analytics for batch release, deviation management, and process monitoring. For sponsors, the strongest partnerships will be built around shared governance, clear escalation pathways, lifecycle cost visibility, and jointly defined metrics for quality, speed, yield, and supply continuity.

Research Methodology for the Pharmaceutical Contract Manufacturing Analysis

This executive summary is based on triangulation of publicly available and verifiable sources, including regulatory agency publications, GMP guidance, drug approval databases, company disclosures, trade data, and documented industry capacity trends. Key references include FDA approval statistics, FDA discussions on AI and machine learning in drug development, ICH quality guidelines, EMA and EU GMP frameworks, and national pharmaceutical policy signals.

The analysis emphasizes evidence-backed market drivers, regulatory developments, regional manufacturing capabilities, and observable outsourcing patterns. Qualitative insights were assessed through cross-comparison of sponsor needs, CDMO service models, supply chain resilience priorities, and technology adoption in regulated pharmaceutical manufacturing.

Conclusion: Strategic Outlook for Pharmaceutical Contract Manufacturing

Pharmaceutical contract manufacturing is entering a more strategic phase defined by complexity, compliance, digitalization, and supply chain resilience. Sponsors increasingly require CDMOs that can deliver technical depth, regulatory confidence, and scalable execution across APIs, biologics, sterile products, and finished dosage forms.

As AI, advanced analytics, and global supply diversification mature, competitive advantage will shift toward organizations that combine operational excellence with validated digital systems and regionally resilient networks. Organizations that align outsourcing strategy with quality, risk, and speed-to-market objectives will be best positioned to capture long-term value in the pharmaceutical contract manufacturing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Contract Manufacturing Market, by Service Type
7.1. Analytical Services
7.1.1. Bioanalytical Services
7.1.2. Method Development
7.1.3. Stability Studies
7.2. Development Services
7.2.1. Formulation Development
7.2.2. Process Development
7.3. Filling Services
7.3.1. Syringe Filling
7.3.2. Unit Dose Filling
7.3.3. Vial Filling
7.4. Manufacturing Services
7.4.1. Liquid Orals
7.4.2. Solid Oral Dosage
7.4.3. Sterile Injectables
7.4.4. Topical Formulations
7.5. Packaging & Labeling
7.5.1. Primary Packaging
7.5.2. Secondary Packaging
8. Pharmaceutical Contract Manufacturing Market, by Molecule Type
8.1. Biologics
8.2. Small Molecule
9. Pharmaceutical Contract Manufacturing Market, by Dosage Form
9.1. Liquid Dosage
9.1.1. Oral Solutions
9.1.2. Suspensions
9.2. Solid Dosage
9.2.1. Capsules
9.2.2. Tablets
9.3. Sterile Injectables
9.4. Topical Dosage
9.4.1. Creams & Ointments
9.4.2. Gels
10. Pharmaceutical Contract Manufacturing Market, by Contract Type
10.1. Dedicated
10.2. Non Dedicated
11. Pharmaceutical Contract Manufacturing Market, by Production Scale
11.1. Clinical Trial
11.1.1. Phase I
11.1.2. Phase II
11.1.3. Phase III
11.2. Commercial
12. Pharmaceutical Contract Manufacturing Market, by Application
12.1. Infectious Diseases
12.2. Cardiovascular Diseases
12.3. Neurological Disorders
12.4. Metabolic Disorders
12.5. Autoimmune Diseases
13. Asia-Pacific Pharmaceutical Contract Manufacturing Market
14. North America Pharmaceutical Contract Manufacturing Market
15. Latin America Pharmaceutical Contract Manufacturing Market
16. Europe Pharmaceutical Contract Manufacturing Market
17. Middle East Pharmaceutical Contract Manufacturing Market
18. Africa Pharmaceutical Contract Manufacturing Market
19. ASEAN Pharmaceutical Contract Manufacturing Market
20. GCC Pharmaceutical Contract Manufacturing Market
21. European Union Pharmaceutical Contract Manufacturing Market
22. BRICS Pharmaceutical Contract Manufacturing Market
23. G7 Pharmaceutical Contract Manufacturing Market
24. NATO Pharmaceutical Contract Manufacturing Market
25. United States Pharmaceutical Contract Manufacturing Market
26. Canada Pharmaceutical Contract Manufacturing Market
27. Mexico Pharmaceutical Contract Manufacturing Market
28. Brazil Pharmaceutical Contract Manufacturing Market
29. United Kingdom Pharmaceutical Contract Manufacturing Market
30. Germany Pharmaceutical Contract Manufacturing Market
31. France Pharmaceutical Contract Manufacturing Market
32. Russia Pharmaceutical Contract Manufacturing Market
33. Italy Pharmaceutical Contract Manufacturing Market
34. Spain Pharmaceutical Contract Manufacturing Market
35. China Pharmaceutical Contract Manufacturing Market
36. India Pharmaceutical Contract Manufacturing Market
37. Japan Pharmaceutical Contract Manufacturing Market
38. Australia Pharmaceutical Contract Manufacturing Market
39. South Korea Pharmaceutical Contract Manufacturing Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Aenova Group GmbH
41.2. AGC Biologics
41.3. Akums Drugs & Pharmaceuticals Ltd.
41.4. Almac Group
41.5. Aragen Life Sciences
41.6. Ardena Holding NV
41.7. Asymchem Laboratories (Tianjin) Co., Ltd.
41.8. Boehringer Ingelheim International GmbH
41.9. Cambrex Corporation
41.10. Catalent, Inc.
41.11. Charles River Laboratories International, Inc.
41.12. CordenPharma
41.13. Curia Global, Inc.
41.14. Delpharm
41.15. Eurofins Scientific SE
41.16. Evonik Industries AG
41.17. Fareva SA
41.18. Fujifilm Diosynth Biotechnologies
41.19. Jubilant Pharmova Limited
41.20. Lonza Group Ltd.
41.21. Merck KGaA
41.22. Neuland Laboratories Limited
41.23. PCI Pharma Services
41.24. Piramal Pharma Solutions
41.25. Porton Pharma Solutions Ltd.
41.26. Recipharm AB
41.27. Sai Life Sciences Ltd.
41.28. Samsung Biologics Co., Ltd.
41.29. Siegfried Holding AG
41.30. Simtra BioPharma Solutions
41.31. Syngene International Limited
41.32. Thermo Fisher Scientific Inc.
41.33. Vetter Pharma-Fertigung GmbH & Co. KG
41.34. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANALYTICAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANALYTICAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANALYTICAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOANALYTICAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOANALYTICAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOANALYTICAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL METHOD DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL METHOD DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL METHOD DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STABILITY STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STABILITY STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL STABILITY STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DEVELOPMENT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FORMULATION DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FORMULATION DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FORMULATION DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PROCESS DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PROCESS DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PROCESS DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FILLING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FILLING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FILLING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SYRINGE FILLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SYRINGE FILLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SYRINGE FILLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL UNIT DOSE FILLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL UNIT DOSE FILLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL UNIT DOSE FILLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VIAL FILLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VIAL FILLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VIAL FILLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MANUFACTURING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LIQUID ORALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LIQUID ORALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LIQUID ORALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SOLID ORAL DOSAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SOLID ORAL DOSAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SOLID ORAL DOSAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL STERILE INJECTABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL STERILE INJECTABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL STERILE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TOPICAL FORMULATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TOPICAL FORMULATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PACKAGING & LABELING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PACKAGING & LABELING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PACKAGING & LABELING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PRIMARY PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PRIMARY PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PRIMARY PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SECONDARY PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SECONDARY PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SECONDARY PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SMALL MOLECULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SMALL MOLECULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SMALL MOLECULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL LIQUID DOSAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL LIQUID DOSAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL LIQUID DOSAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ORAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ORAL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ORAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SUSPENSIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SUSPENSIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SUSPENSIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SOLID DOSAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SOLID DOSAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SOLID DOSAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL STERILE INJECTABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL STERILE INJECTABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL STERILE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TOPICAL DOSAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TOPICAL DOSAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TOPICAL DOSAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DEDICATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DEDICATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DEDICATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NON DEDICATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NON DEDICATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NON DEDICATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CLINICAL TRIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CLINICAL TRIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CLINICAL TRIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PHASE I MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PHASE I MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PHASE I MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PHASE II MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PHASE II MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PHASE II MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PHASE III MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PHASE III MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PHASE III MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL COMMERCIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL COMMERCIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL COMMERCIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 193. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 194. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 195. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 196. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 197. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 198. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 200. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 203. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 204. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 205. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 206. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 224. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 225. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 226. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 227. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 228. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 229. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 230. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 231. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 232. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 233. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 234. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 235. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 236. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 237. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 238. AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 241. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 242. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 243. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 244. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 245. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 246. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 247. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 248. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 249. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 250. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 252. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 253. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 254. ASEAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 256. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 257. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 258. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 259. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 260. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 261. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 262. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 263. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 264. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 265. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 266. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 267. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 268. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 269. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 270. GCC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 288. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 289. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 290. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 291. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 292. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 293. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 294. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 295. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 296. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 297. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 298. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 299. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 300. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 301. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 302. BRICS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 304. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 305. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 306. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 307. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 308. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 309. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 310. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 311. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 312. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
TABLE 313. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 314. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2032 (USD MILLION)
TABLE 315. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2032 (USD MILLION)
TABLE 316. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2032 (USD MILLION)
TABLE 317. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2032 (USD MILLION)
TABLE 318. G7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 319. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 320. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 321. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2032 (USD MILLION)
TABLE 322. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 323. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2032 (USD MILLION)
TABLE 324. NATO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 325. NATO PHARMACEUTICAL CONTRACT MANUFACTU

Companies Mentioned

The companies featured in this Pharmaceutical Contract Manufacturing market report include:
  • Aenova Group GmbH
  • AGC Biologics
  • Akums Drugs & Pharmaceuticals Ltd.
  • Almac Group
  • Aragen Life Sciences
  • Ardena Holding NV
  • Asymchem Laboratories (Tianjin) Co., Ltd.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • CordenPharma
  • Curia Global, Inc.
  • Delpharm
  • Eurofins Scientific SE
  • Evonik Industries AG
  • Fareva SA
  • Fujifilm Diosynth Biotechnologies
  • Jubilant Pharmova Limited
  • Lonza Group Ltd.
  • Merck KGaA
  • Neuland Laboratories Limited
  • PCI Pharma Services
  • Piramal Pharma Solutions
  • Porton Pharma Solutions Ltd.
  • Recipharm AB
  • Sai Life Sciences Ltd.
  • Samsung Biologics Co., Ltd.
  • Siegfried Holding AG
  • Simtra BioPharma Solutions
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 164.71 Billion
Forecasted Market Value ( USD ) by 2032 $ 297.88 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned35

Related Topics

Related Reports

Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, Molecule Type, Dosage Form, Application - Global Forecast 2026-2032 - Product Image

Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, Molecule Type, Dosage Form, Application - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Oral Solid Dosage Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
High Potency API Contract Manufacturing - Global Strategic Business Report - Product Image

High Potency API Contract Manufacturing - Global Strategic Business Report

  • Report
  • 466 Pages
  • Global
From
Generic Pharmaceuticals Contract Manufacturing - Global Strategic Business Report - Product Image

Generic Pharmaceuticals Contract Manufacturing - Global Strategic Business Report

  • Report
  • 494 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Service, Product, Drug, Scale of Operation, Workflow, Application, End Use, Company, Region, and Growth Forecasts, 2026-2033 - Product Image

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Service, Product, Drug, Scale of Operation, Workflow, Application, End Use, Company, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From

About the Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing (PCM) is a type of pharmaceutical manufacturing in which a company outsources the production of a drug or medical device to a third-party manufacturer. This type of manufacturing is often used when a company does not have the resources or expertise to produce a product in-house. PCM can also be used to reduce costs, increase production capacity, and improve product quality. PCM services can include formulation development, process optimization, analytical testing, packaging, and labeling. The contract manufacturer is responsible for ensuring that the product meets all regulatory requirements and is of the highest quality. Some of the major players in the PCM market include Patheon, Catalent, Recipharm, Aenova, and Vetter. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.